Clinical pharmacology, physiology and pathophysiology of superficial veins--2.
Sandoz Pharma Ltd, Basel, Switzerland.
W H
WH
Aellig
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D002118:Calcium / Q000037:antagonists & inhibitors; D004347:Drug Interactions; D004876:Ergot Alkaloids / Q000494:pharmacology; D005121:Extremities / Q000098:blood supply; D006801:Humans; D066298:In Vitro Techniques; D009566:Nitrates / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D011976:Receptors, Muscarinic / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*; D014680:Veins / Q000187:drug effects* / Q000473:pathology / Q000502:physiology
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004876:Ergot Alkaloids; D009566:Nitrates; D011453:Prostaglandins; D011976:Receptors, Muscarinic; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D000804:Angiotensin II; D012701:Serotonin; D002118:Calcium